Rapamycin reliably extends lifespan across multiple sites

National Institute on Aging (NIA)/Interventions Testing Program (ITP)

The ITP found that rapamycin extended lifespan in mice of both sexes by 10-25%, establishing rapamycin as a benchmark for lifespan-extending compounds.